Physician

Aaron Kenneth Clark, M.D.

According to 2025 Medicare claims, Aaron Clark, M.D. (NPI: 1235113382) practices family practice in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from St. Clair, MI. This provider's primary affiliated billing organization is AARON K. CLARK MD PC (NPI: 1477740090; TIN: 371446643) and primary practice location at 48060-3571. Clark is affiliated with the Aledade 57 Western Sky MSSP Enhanced (ACO ID: A4756) and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Clark's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 257 traditional Medicare patients, billed 4,656 HCPCS/CPT codes, and received $144,907 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,970 prescription claims across 648 beneficiaries totaling $1,098,726 in drug costs, led by Eliquis (Apixaban). DME data shows 88 claims. Open Payments data shows 36 records totaling $637. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $161,708 to $144,907. In contrast, Part D prescription costs have moved sharply higher in recent years, from $298,920 to $1,098,726. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $20,233 and ending at $11,671.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	525	3,656	$161,708
2016	525	4,641	$215,612
2017	486	4,109	$201,212
2018	460	3,988	$201,969
2019	368	4,189	$184,687
2020	344	4,079	$175,469
2021	305	3,756	$176,143
2022	289	2,881	$131,617
2023	264	2,560	$130,494
2024	257	4,656	$144,907

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	519	4,043	$298,920
2016	611	7,478	$603,713
2017	622	7,979	$651,298
2018	603	7,296	$567,267
2019	518	4,607	$384,661
2020	473	5,510	$453,623
2021	487	6,087	$560,284
2022	585	8,257	$960,769
2023	644	11,241	$1,486,768
2024	648	8,970	$1,098,726

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	145	525	$15,964
2016	137	576	$15,052
2017	182	542	$14,158
2018	78	311	$8,114
2019	41	169	$2,979
2020	36	93	$1,613
2021	36	115	$1,707
2022	35	143	$4,974
2023	31	150	$6,918
2024	16	88	$8,137

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	197	197	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	200	544	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	232	552	$56
36415	Insertion of needle into vein for collection of blood sample	212	406	$8
81002	Urinalysis, manual test	98	146	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	130	8,154	$146,705
Trulicity	Dulaglutide	87	4,420	$140,680
Jardiance	Empagliflozin	81	5,272	$100,960
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	100	4,230	$86,753
Januvia	Sitagliptin Phosphate	39	2,915	$50,727

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	14	$6,786
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	16	44	$746
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	13	$579
A4259	Lancets, per box of 100	N	N/R	17	$27

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$637	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Kenneth Clark, M.D.?

Tedicare shows public-source Medicare data for Aaron Kenneth Clark, M.D. (NPI 1235113382), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Kenneth Clark, M.D. have ACO affiliation data?

Aaron Kenneth Clark, M.D. is shown with ACO affiliation data for Aledade 57 Western Sky MSSP Enhanced (MSSP, ACO ID A4756) and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Aaron Kenneth Clark, M.D.?

Aaron Kenneth Clark, M.D. is linked to AARON K. CLARK MD PC (billing NPI 1477740090) in the available physician profile data.

Does Aaron Kenneth Clark, M.D. have Open Payments data?

Aaron Kenneth Clark, M.D. has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.